CD24 and cancer: Furthermore, the decrease in cancer stem cells surface markers phenotype (CD90, CD44, CD133, CD13 and CD24) observed in combined DATP and XAV939 was no more than that observed by either individual treatment, suggesting that Notch and Wnt/β-Catenin may have cross-talk between each other.